Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 75.00%
Date: 10-04-2026
Price: $0.530
Last Price: $0.600
Post-Signal Low Price: $0.510
Aroa Biosurgery Limited (ASX:ARX) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissu
AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivered s
AUCKLAND, New Zealand, Sept. 14, 2022 /PRNewswire/ -- New Zealand based soft tissue regeneration company Aroa Biosurgery (AROA) is delighted to announce the appointment of award-winning medical researcher and inventor, Dr. Catherine Mohr as a Non-Executive Director to the board. AROA's products are
Over the last month the Aroa Biosurgery Limited (ASX:ARX) has been much stronger than before, rebounding by 32%. But that is minimal compensation for the share price under-performance over the last year. In fact, the price has declined 21% in a year, falling short of the returns you could get by inv
Aroa Biosurgery Limited (ASX:ARX) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissu
AI Confidence - 75.00 % model confidence
AROA Biosurgery Limited develops and commercializes advanced surgical products focused on regenerative medicine and wound healing. The company operates primarily in the medical devices sector, targeting hospitals and surgical centers with innovative biomaterial solutions designed to improve patient outcomes. It holds a niche market position with a growing presence in the regenerative surgery space.
| Cash Flow | Weak |
| Debt | Moderate |
| Profitability | Weak |
| Revenue Trend | Downtrend |
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Oversold |
| Support Level | $ 0.50 |
| Resistance Level | $ 0.60 |